chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He got his vaccine, and had a squeezing sensation in his xiphoid process area or middle of his chest.  Then he started having terrible nightmares, which he still has to this day.  Then he started getting heart pains and shortness of breath, as well as blurry vision.  Her oxygen saturation now stays in-between 91-95, but if he takes deep breaths he can get it up to 97.  He went to his doctor who sent him to a sleep specialist and gave him a C-PAP as he has sleep apnea since getting the vaccine.   He was supposed to go to the pulmonologist today but due to the snow he had to reschedule that appointment.  He is still having low oxygen, shortness of breath and the sleep apnea.  He was put on Meloxicam 15 mg once a day, Phentermine 37.5 mg. once a day, Levothyroxine 0.75 mg, Vraylar 1.5 mg, Bupropion 100 mg, and Melatonin .   These medicine do help him some, he did have suicidal thoughts and these do seem to assist with those reactions.   He was hospitalized one time at Hospital, and then hospital once he was having suicidal thoughts.  He was admitted for bradycardia for a day as it was between 30-50 BPM, and sent him home once under control.  He does see a cardiologist.  He has bad dreams at night, and he could jog a mile a few times a week prior to the vaccine, and now has trouble walking a block.  When he lies down at night his oxygen saturation goes down faster than when he's sitting up.  His psychiatrist is NP.  He was  not under psychiatric care prior to the vaccine, and had no medical issues at all prior to the vaccine.   He has gained weight and takes Adipex now.   His doctor recommended that he not get any further vaccines.    He has cloudiness of his thoughts, responds slow and was high speed and his friends tell him he is now dial up.  He does not seem to think as quick as he did before, foggy headed.   He has had trouble having bowel movements and used to go twice every morning, and now has to take Laxatives and only goes about every 4 days.
Patient reported she had gone to Urgent Care the day after she had her PNEUMOVAX immunization. She had pain, redness, and swelling in a 4-inch band from the injection site to her elbow. Patient was given TYLENOL with codeine, a steroid cream, and "another medication". Symptoms lasted 4 days.
For 2-3 days after the shot my arm was red, swollen and hard.  This subsided, but then on day 7 I developed a rash and swelling at injection shot in an area approximately 3 x 4".  This has subsided after 2 days, but then on day 10 my entire body started to itch, I developed a rash on my arms and chest  and hives on my forearms and legs.  Day 11 - still experiencing these symptoms, but a little less than the day before.
Parent noted symptoms around dinner time on 3/19/2014. Redness and itching noted. Area noted pink and itchy on 03/20/14. No increase in area size noted per parent.
Patient informed nurse that he usually faints after receiving injections.  Patient given one injections (Hepatitis A) while lying on exam table.  10 minutes after injection, patient complained that he could not move right arm (arm that received injection). Patient left clinic walking on his own.  Telephone call 3/17/09, reports no complaints about arm when arrived home, did fine throuthout the evening.  Doing well today (3/17/09), no complaints.
~9 d. s/p vaccination developed fever & Chills ® 12 d. s/p vaccine developed progressive dyspnea and mid-chest pain ® evaluated overseas ® evac'd back to US for further evaluation
Patient began febrile episode on 1/31 with fever up to 102.4 F lasting 3 days. Patient was taken  to physician and upon examination no signs of  infections noted.  On 2/4 after fever subsided, rash appeared over entire body per parents.  Rash remains on body as of today,2/5/09 with no other symptoms of reactions reported.
Small red bumps on front & back of trunk, (L)/(R) arms and (R)/(L) legs. No pus oozing. Pt states the bumps are itchy and started appearing Fri after receiving shots on Tue 17 May 11.
Dizziness, Headache & Palpitations Narrative:  Palpitation s/p covid vaccine 1 hour Employee claimed that she  had fast heart beat an hour after covid vaccine injection There is associated  dizziness.  Employee denied chest pain, sob , fever, nausea, vomiting
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 25-NOV-2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 14-DEC-2015, the patient was treated by a Nurse Practitioner for a persistent and severe vesicular rash, which was diagnosed as herpes zoster. The patient has been prescribed Neurontin and acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
Submitted to Docket No. 1980N-0208; 69 FR 78281, December 29, 2004 - Bacterial Vaccines & Toxoids Efficacy Review Proposal. Developed autoimmune optic neuritis following vaccination. He also developed numbness and tingling on one half of his body. He has signs and symptoms consistent with Multiple Sclerosis (MS). To the best of my knowledge he no longer flies. (OMIC)
Shoulder Pain Narrative: Patient's report "I was unable to move my bowels for three days after the shot but had not had a movement 2 days prior to the shot. Another affect I experienced was severe shoulder pain to the point of immobility for 4 days and consideral pain in that shoulder."
tested COVID-19 positive; tested COVID-19 positive; This is a spontaneous report from a Pfizer sponsored  reported by contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 via an unspecified route of administration on 04Mar2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that she received the 1st dose of vaccine last 03/04 and she is due for the 2nd dose on 03/25 (exactly 21 days apart). Patient tested COVID-19 positive (on an unspecified date) and wants to make sure if she can still take the 2nd dose after being cleared. The outcome of event was unknown.   Information on the lot/batch number has been requested.
There were 4-5 individuals at the local clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No adverse reaction symptoms
Developed myopericarditis in November of 2022. He was hospitalized as well. He continues to have problems today.
Information has been received from a physician concerning a patient's father who in "1950's" was vaccinated with MMR II (manufacturer unknown). Subsequently sometime in 1950's he experienced an anaphylactic reaction and was hospitalized. It was reported that the patient's father did not know anything else because he was too little. He was just told that he had a "bad reaction" and was hospitalized for an anaphylactic reaction. He was treated in the hospital, but eventually recovered. Anaphylactic reaction was considered to be immediately life-threatening and an other important medical event. The patient's aunt (WAES # 0606USA00077) had a similar experience following vaccination with MMR II. No further information is available.
This spontaneous report was received from a licensed practical nurse refers to a 39 year old patient, gender unspecified. Approximately on an unknown date in April 2008 (reported as four years ago) the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date and route not reported) to prevent herpes simplex. No adverse effect reported. Additional information has been requested.
Covid positive 1.20.22. Presents with worsening DOE and mild cough. Decompensated CHF. Treated with lasix and antibiotics.
Redness, swelling, itching, pain and rash occurred around injection site on left arm where Covid vaccination was administered.  Area is ~6 inches in diameter currently.   Symptoms started 4-5 hours after vaccination was received but diameter of rash/redness enlarged over the next several days.    Symptoms have not subsided at this point.  I did not have a rash/redness with the first and second dose that I received on 12/21/20 and 1/12/21.    I receive the flu shot annually and have never had a reaction.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hodgkins Lymphoma survivor" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization completed, manufacturer unknown), for Covid-19 immunization.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19, which included Paxlovid from 19Apr2022 to 23Apr2022. After taking Paxlovid for 5 days and feeling great, the patient became sick again on 28Apr2022 with worse symptoms for which no treatment was given and she was recovering from it.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Stuffy nose; swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node; Could not sleep for 3 plus hours; Woke up groggy; Intermittent sweats; overheating; Very tired; Arm/injection site soreness and pain lifting arm above head; Arm/injection site soreness and pain lifting arm above head; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the right arm on 14Apr2021 at 13:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and herpes simplex type ii (HSV2). The patient was allergic to sulfa meds. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, on day 1 of vaccination, the patient felt very tired, arm/injection site soreness, pain lifting arm above head. On 15Apr2021, on day 2 of vaccination, the patient was tired, had intermittent sweats/overheating. The patient had no fever or chills. On evening day 2 the patient fell asleep around 21:00 just tired, awake around 00:30 on 16Apr2021 with stuffy nose and swollen lymph node under armpit of injection arm (right arm); the patient couldn't sleep for 3+ hours due to pain of swollen lymph node, approximately size of clementine; eventually slept again, on day 3, 16Apr2021 the patient woke up groggy, alert but tiring easily as the patient tried to work (computer/office job from home). Lymph node swelling down considerably but not gone and still was painful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very tired, arm/injection site soreness and pain lifting arm above head, intermittent sweats, overheating, woke up groggy, stuffy nose, swollen lymph node under armpit of injection arm right arm could not sleep for 3 plus hours due to pain of swollen lymph node were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Elevate your liver enzymes; ALT (Alanine transaminase) was high or elevated; This non-serious case was reported by a consumer via call center representative and described the occurrence of elevated liver enzymes in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced elevated liver enzymes (Verbatim: Elevate your liver enzymes) and alanine aminotransferase increased (Verbatim: ALT (Alanine transaminase) was high or elevated). The outcome of the elevated liver enzymes and alanine aminotransferase increased were unknown.   It was unknown if the reporter considered the elevated liver enzymes and alanine aminotransferase increased to be related to Shingrix.     It was unknown if the company considered the elevated liver enzymes and alanine aminotransferase increased to be related to Shingrix.   Additional Information: GSK Receipt Date: 22-MAR-2023 The case was reported to GSK via interactive digitial media regarding Shingrix. The reporter was the patient.  Patient asked GlaxoSmithKline that could vaccine elevate liver enzymes. While outbound call was made to answer the question, patient indicated that she had the second dose of Shingrix and then had blood work done which showed that her Liver function enzymes (LFT-Liver Function Test)  specifically ALT (Alanine transaminase) high/elevated.  The reporter consented to follow up but did not provided her email address.
Headache; Nausea; Body ache; Muscle soreness; Joint pain; Fatigue; This is spontaneous report from contactable consumer, the patient. A 37-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6204), via an unspecified route of administration in the right arm on 16Mar2021 at 15:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. The Patient had allergic to Penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. On 21Mar2021 at 13:00, the patient experienced headache, nausea, body ache, muscle soreness, joint pain and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. The patient had nasal swab (COVID-19 virus test) on 22Mar2021 and the result was pending. The patient did not receive any treatment for the events. The clinical outcome of the events headache, nausea, body ache, muscle soreness, joint pain, and fatigue were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
During the early morning hours I woke up after a fretful sleep. I got out  of bed and I fell to the floor. Strength in my muscles was reduced to the extent that I could not move and I spent the remainder of the night on the floor unable to rise up from th e floor or to operate my limbs. By the time I got up in the morning  the morning the symptoms were gone.
This spontaneous report as received from a nurse who refers to multiple unspecified patients of unknown age and gender. The multiple patient's medical history and concurrent conditions were not reported. On an unspecified date in February 2016, multiple patients were vaccinated with improperly stored doses of PROQUAD lot # L039269 expiration date 04-APR-2017. Dose, route and anatomical location were not provided. Other suspect vaccine reported was PEDVAXHIB. No other concomitant medications were reported. Excursion details: The vaccine was exposed to -13 degrees F for a total of 184 hours. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
The symptoms included: persistent vomiting, severe menstrual pain, dizziness, numbness of extremities (arms and legs) and cold sweating.
Pt DOB 09/07/1989 presented to the  local HCF outreach event on 11/04/2021. The client notified PHN that he received a single dose of a COVID vaccine out of state ?about 4 months ago.?  The client did not know the name of the vaccine or the exact date he received it.  He did not have a vaccine card.   PHN checked the database but there was no record of COVID vaccination for the client.   PHN submitted a medical consult via text message to the Vaccine Operations Leads, requesting to proceed with the Janssen COVID vaccine. Per CDC guidance, approval to proceed with the Janssen vaccine was obtained from the medical consult team via text message from Dr. that was forwarded to PHN by the Vaccine Operations Lead.  The client received the Janssen vaccine lot # 1855194 on 11/04/2021. The client did not report any symptoms during the 30 minute observation period.  PHN educated the client about possible adverse reactions and when to seek medical care.  The client walked away from the vaccination area with a steady gait at 0930am and sat down to wait for transportation from the event
pt to ED after seeing PCP and being positive for COVID; needs hemodialysis tomorrow; c/o slightly productive cough, chronic SOB; O2 sat 88% on RA in ED; placed on O2 via NC; COVID test in ED negative but treating pt as positive; given antibiotics; respiratory status worsened requiring high levels of O2; OptiFlow; given dexamethasone; one of 2 blood cultures are positive for MSSA; pt has increasing weakness and is on 9-10L O2; pt made a DNI/DNR; mental status declined and pt's condition worsened; he died in the hosp
Started my period 2 weeks early almost immediately after receiving the 1st dose of vaccine, despite taking hormonal birth control daily that is supposed to regulate my monthly period.
pt was observed for 15 minutes after vaccine administration and stated he felt light headed and dizzy, we watched pt for additional 15 mins he was AAO. He then complained of a "scratchy throat" and had hives on his stomach. Benadryl cc was given IM in RT deltoid (lot # 119314 exp date: 11/2021). Pt was observed for 15 more minutes. He states he was taking Lisinopril for his BP but was not complaint and also stated he was allergic to penicillin, despite answering "no" on our questionnaire regarding any allergies. No signs of facial/tongue/lip swelling, patient complained the tightness in his throat had gotten worse, so EMS was called to further assess patient. EMS arrived at 8:45 am and pt decline going to ED.
blood clot on spleen; This spontaneous case was reported by a consumer and describes the occurrence of SPLENIC THROMBOSIS (blood clot on spleen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SPLENIC THROMBOSIS (blood clot on spleen) (seriousness criterion medically significant). At the time of the report, SPLENIC THROMBOSIS (blood clot on spleen) outcome was unknown. Not Provided          Treatment information was not provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD21-076398, US-MODERNATX, INC.-MOD-2021-078083 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. MOD21-076398: US-MODERNATX, INC.-MOD-2021-078083:
booster shot; baseball sized lymph node swell under his arm at the side of the injection in left arm; could not put his arm down; felt ill; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose Number: 2, Batch/Lot No: Unknown, unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose Number: 1, Batch/Lot No: Unknown, unknown manufacturer), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 16Dec2021, outcome "unknown", described as "booster shot"; VACCINATION SITE LYMPHADENOPATHY (non-serious) with onset 16Dec2021, outcome "recovering", described as "baseball sized lymph node swell under his arm at the side of the injection in left arm"; LIMB DISCOMFORT (non-serious) with onset 16Dec2021, outcome "recovering", described as "could not put his arm down"; MALAISE (non-serious) with onset 16Dec2021, outcome "recovering", described as "felt ill". Therapeutic measures were not taken as a result of vaccination site lymphadenopathy, limb discomfort, malaise.  Additional Information: The patient did not receive other vaccine in four weeks. The patient had not COVID prior vaccination and COVID tested post vaccination.  The reporter stated that the reporter was talking to daughter on Sunday, 19Dec2021, and she told that she and her husband got the booster shot on Thursday and experienced a close to a baseball sized lymph node swell under his arm at the side of the injection in left arm. He could not put his arm down. The reporter asked if he saw a doctor and he said he had not. As spoke to her the swelling had gone down to about the size of a golf ball. She got it too and they both felt ill also.  She felt that since his swelling was going down he would not go to the doctors.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Severe hives all over the body starting a few days after the booster shot, lasting several weeks with persisting skin sensitivity. Took a steroid pack for a week on top of antihistamines which kept the reaction to a tolerable level. Continuing to take antihistamine daily as symptoms persist.
Patient reported a reaction to the COVID bivalent vaccine on 1/23/23 via a survey:  Swelling of your face and throat; A fast heartbeat; Dizziness and weakness; Other: Loss of hearing and sight problems.  Reported to have occurred within 4 hours of administration.  No visibility to any sort of clinic visit or care sought?